Methylamine

Methylamine

SCHEMBL110166

CCC[Si](OC)(OC)OC.CN

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrazine SCHEMBL28825171 0.94 LMNA (0.41) LMNA
SCHEMBL8130395 0.94 LMNA (0.44) LMNA
SCHEMBL35169 0.94 LMNA (0.44) LMNA
SCHEMBL28880717 0.91 LMNA (0.40) LMNA
Ethylamine SCHEMBL1367867 0.91 LMNA (0.40) LMNA
Ammonia Solution, Strong SCHEMBL819686 0.90 LMNA (0.43) LMNA
Water SCHEMBL1968372 0.90 LMNA (0.43) LMNA
SCHEMBL30297175 0.90 LMNA (0.43) LMNA
Hydrochloric Acid SCHEMBL524172 0.90 LMNA (0.43) LMNA
SCHEMBL9717789 0.90 LMNA (0.43) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1695 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4048742-B1 AQUEOUS COMPOSITION OF ORGANIC POLYMERIC MICROSPHERES, BINDER PARTICLES, AND ION EXCHANGE RESIN ROHM & HAAS (US) 2026-03-11 EP claimed
US-12558725-B2 Polymer-mediated particle coarsening within hollow silica shell nanoreactors NORTHWESTERN UNIVERSITY (US) 2026-02-24 US claimed
EP-4683955-A1 ANTI-FOG COATINGS AND METHOD OF USING THE SAME Actnano, Inc. (US) 2026-01-28 EP claimed
EP-4649120-A1 ADHESIVE COMPOSITIONS FOR LOW ENERGY SURFACES AND ADHESIVES THEREFROM Henkel AG & Co. KGaA (DE) 2025-11-19 EP claimed
WO-2025224574-A1 COATED NONWOVEN POROUS ARTICLE 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-10-30 WO claimed
US-20250326910-A1 METHOD FOR PRODUCING SURFACE-MODIFIED MICRO-FIBRILLATED CELLULOSE DÄTWYLER SCHWEIZ AG (CH) 2025-10-23 US claimed
US-20250281904-A1 SORBENT NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (NO) 2025-09-11 US claimed
EP-4561745-A1 SORBENT Norwegian University Of Science And Technology (NO) 2025-06-04 EP claimed
EP-4532567-A1 METHOD FOR PRODUCING SURFACE-MODIFIED MICRO-FIBRILLATED CELLULOSE Dätwyler Schweiz AG (CH) 2025-04-09 EP claimed
US-12257314-B2 Extended nitric oxide-releasing polymers via functionalized mesoporous silica nanoparticles THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2025-03-25 US claimed
US-5370922-A Aminosilanes for non-bleed aqueous liquid paper ROHM AND HAAS COMPANY (US) 1994-12-06 US claimed
WO-1994025406-A1 METHOD FOR THE FABRICATION OF TRANSPARENT DENSE GLASSES OBTAINED FROM SILICONE ALKOXYDES OR METAL ALKOXYDES BY THE SOL-GEL ROUTE, AND GLASSES OBTAINED ACCORDING TO SUCH METHOD ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) 1994-11-10 WO claimed
EP-0622427-A2 Use of a coating comprising an acid-functional polymer and an organosilane ROHM AND HAAS COMPANY (US) 1994-11-02 EP claimed
EP-0605225-A1 Process for preparation of beta-cyanoalkylsilanes DOW CORNING CORPORATION (US) 1994-07-06 EP claimed
US-5262554-A Hydrosilylation, supported aminosilane catalyst DOW CORNING CORPORATION (US) 1993-11-16 US claimed
US-5247109-A Aminosilane catalyst DOW CORNING CORPORATION (US) 1993-09-21 US claimed
EP-0544672-A1 HOT MELT MOISTURE-CURE POLYURETHANE ADHESIVE. FULLER H B LICENSING FINANC (US) 1993-06-09 EP claimed
WO-1992005433-A1 CONTINUOUS POSITIVE CHARGE CAPILLARY COLUMNS USED IN CAPILLARY ELECTROPHORESIS KERR ROBERT (FR) 1992-04-02 WO claimed
WO-1991015530-A1 HOT MELT MOISTURE-CURE POLYURETHANE ADHESIVE H.B. FULLER LICENSING & FINANCING INC. (US) 1991-10-17 WO claimed
US-4758624-A Silane-crosslinkable halogenated polymer composition and process of crosslinking the same FUJIKURA LTD. (JP) 1988-07-19 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12558725-B2 Polymer-mediated particle coarsening within hollow silica shell nanoreactors SGMS2, SGMS1, CERS2 LMNA 661/4885
US-12257314-B2 Extended nitric oxide-releasing polymers via functionalized mesoporous silica nanoparticles NOS3, NOS2, NOS1 LMNA 1189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.